Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus midazolam for ICU sedation in mechanically ventilated adults
ChiCTR2200060314Phase 4Recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and midazolam in acute respiratory distress syndrome (ARDS) (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoints: Duration of mechanical ventilation and EEG waveform changes during sedation maintenance. Started Jun 2022; status: recruiting.
02
Drugs
remimazolammidazolam
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on ChiCTR2200060314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060314.